𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines

✍ Scribed by Lauren A. Licata; Christine L. Hostetter; James Crismale; Anjali Sheth; Judith Clancy Keen

Publisher
Springer US
Year
2009
Tongue
English
Weight
561 KB
Volume
122
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL-1β induces stabilization of IL-8 mRNA
IL-1β induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3′ untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR
✍ Esther A. Suswam; L. Burt Nabors; Yuanyuan Huang; Xiuhua Yang; Peter H. King 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB

IL-8 plays an integral role in promoting the malignant phenotype in breast cancer, and its production is directly influenced by inflammatory cytokines in the tumor microenvironment. Here, we show that activation of IL-1␤ receptors on malignant HS578t and MDA-MB-231 breast cancer cells strongly induc

Ectopic expression of the ErbB-3 binding
Ectopic expression of the ErbB-3 binding protein Ebp1 inhibits growth and induces differentiation of human breast cancer cell lines
✍ Tracy J. Lessor; Joo-Yeon Yoo; Xianmin Xia; Nicholas Woodford; Anne W. Hamburger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

Ebp1, an ErbB-3 binding protein, translocates from the cytoplasm to the nucleus of human breast cancer cells after treatment with the ErbB-3 ligand, heregulin. The purpose of these studies was to examine the effects of ectopic expression of ebp1 on the biological properties of human ErbB-3-expressin

CCAAT/enhancer binding protein δ (C/EBPδ
CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines
✍ G.S. Sivko; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in